Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Related news articles
Rotation angle sensor
Method for resource allocation in a wireless communication network, method for error-free transmission of information, node and wireless communication network
Behavioral fingerprint based authentication
Method for installing industrial components in an environment
Fibrous laminate interface for security coatings
Systems and methods for identifying malicious domains using internet-wide DNS lookup patterns
  Randomly Featured Patents
Portable communication device
Episulfide compound
Stent crimper
Time management control method for computer system, and computer system
Network telephony appliance and system for inter/intranet telephony
Outdoor working automating system
Method of reducing micro-scratches during tungsten CMP
Method for fishing lines in serial conduits
Brassiere pad fabrication
Adaptive compensation for carrier signal phase distortion